U.S. FDA asks five firms to recall diabetes drug with high levels of probable carcinogen
The U.S. Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication.
from Reuters: Health News https://reut.rs/2XCrAXW
https://bit.ly/2zwRqiM
May 28, 2020
|
Labels:
health,
Reuters: Health News
|
This entry was posted on May 28, 2020
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.